Status:
COMPLETED
Incidence and Patterns of Nausea/Vomiting With Combined Chemotherapy and Radiation
Lead Sponsor:
Thomas Jefferson University
Collaborating Sponsors:
Merck Sharp & Dohme LLC
Conditions:
Cancer of the Head and Neck
Cancer of the Lung
Eligibility:
All Genders
18+ years
Brief Summary
Questionnaire study to observe the incidence and pattern or nausea and vomiting in patients receiving combined chemotherapy and radiation. 83% of patients experience radiation therapy-induced vomiting...
Detailed Description
Questionnaires will be answered daily on a weekly basis during period of radiation and chemotherapy.
Eligibility Criteria
Inclusion
- Concurrent radiation and chemotherapy treatment
- Aerodigestive malignancy
Exclusion
- Other causes of vomiting (i.e.gastrointestinal obstruction...)
Key Trial Info
Start Date :
October 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2011
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00716157
Start Date
October 1 2004
End Date
September 1 2011
Last Update
December 5 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Thomas Jefferson University
Philadelphia, Pennsylvania, United States, 19107